$0.7422
-0.0224-2.93%
Last update: Oct 30, 5:26 AM
Akebia Therapeutics Inc (AKBA) Stock Price, Quote, News & History
AKBANASDAQ
U.S. stock futures mixed, Dow up 100+ points. Western Digital falls after earnings beat expectations but lowers guidance. Other stocks dip in pre-market.
You can purchase shares of Akebia Therapeutics (NASDAQ:AKBA) through any online brokerage.
Other companies in Akebia Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Akebia Therapeutics has a consensus price target of $4.71.
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $0.722 last updated October 30, 2026 at 5:26 AM EDT.
There are no upcoming dividends for Akebia Therapeutics.
Akebia Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Akebia Therapeutics.
Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a...
